NuGene International Inc
Livento Group, Inc., through its subsidiaries, engages in the film and television production business in the United States. The company is also involved in the real estate finance and development; artificial intelligence; and machine learning technology businesses. It also provides Elisee, a software product that read market data and neurological network abilities to determine the path forward an… Read more
NuGene International Inc (NUGN) - Net Assets
Latest net assets as of September 2025: $41.93 Million USD
Based on the latest financial reports, NuGene International Inc (NUGN) has net assets worth $41.93 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($44.52 Million) and total liabilities ($2.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $41.93 Million |
| % of Total Assets | 94.19% |
| Annual Growth Rate | 100.78% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2657.0 |
NuGene International Inc - Net Assets Trend (2013–2024)
This chart illustrates how NuGene International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NuGene International Inc (2013–2024)
The table below shows the annual net assets of NuGene International Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $43.41 Million | +0.90% |
| 2023-12-31 | $43.02 Million | +114.39% |
| 2022-12-31 | $20.07 Million | -0.60% |
| 2021-12-31 | $20.19 Million | +451.76% |
| 2016-12-31 | $-5.74 Million | -1397.03% |
| 2015-12-31 | $-383.37K | -128.03% |
| 2014-12-31 | $1.37 Million | +6636.38% |
| 2013-12-31 | $20.30K | -- |
Equity Component Analysis
This analysis shows how different components contribute to NuGene International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1866090700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $83.04K | 0.19% |
| Other Components | $63.02 Million | 145.21% |
| Total Equity | $43.40 Million | 100.00% |
NuGene International Inc Competitors by Market Cap
The table below lists competitors of NuGene International Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Colibri Resource Corporation
PINK:CRUCF
|
$585.48K |
|
Fbec Worldwide
PINK:FBEC
|
$585.64K |
|
Premier Biomedical Inc
PINK:BIEI
|
$585.78K |
|
Cartica Acquisition Corp Warrant
NASDAQ:CITEW
|
$586.20K |
|
Cyon Exploration Ltd
PINK:CYNXF
|
$584.42K |
|
PureWave Hydrogen Corp.
V:PWH
|
$583.97K |
|
Compuage Infocom Limited
NSE:COMPINFO
|
$583.85K |
|
Golden Star Acquisition Corporation Rights
NASDAQ:GODNR
|
$583.15K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NuGene International Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 43,010,979 to 43,398,937, a change of 387,958 (0.9%).
- Net loss of 596,394 reduced equity.
- New share issuances of 410,261 increased equity.
- Other factors increased equity by 574,091.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-596.39K | -1.37% |
| Share Issuances | $410.26K | +0.95% |
| Other Changes | $574.09K | +1.32% |
| Total Change | $- | 0.90% |
Book Value vs Market Value Analysis
This analysis compares NuGene International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $19.75 | $0.00 | x |
| 2014-12-31 | $1311.30 | $0.00 | x |
| 2015-12-31 | $-192.94 | $0.00 | x |
| 2016-12-31 | $-2853.87 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $-0.13 | $0.00 | x |
| 2021-12-31 | $527.17 | $0.00 | x |
| 2022-12-31 | $0.09 | $0.00 | x |
| 2023-12-31 | $1058.34 | $0.00 | x |
| 2024-12-31 | $1045.20 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NuGene International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -35.26%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 1.10x
- Recent ROE (-1.37%) is below the historical average (-0.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 34.54% | 4.52% | 7.20x | 1.06x | $4.98K |
| 2014 | -22.87% | -43.24% | 0.39x | 1.36x | $-449.55K |
| 2015 | 0.00% | -250.32% | 2.38x | 0.00x | $-5.18 Million |
| 2016 | 0.00% | -2319.42% | 1.57x | 0.00x | $-11.24 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.50K |
| 2021 | -1.06% | -11.67% | 0.09x | 1.01x | $-2.23 Million |
| 2022 | -1.93% | -19.68% | 0.08x | 1.16x | $-2.39 Million |
| 2023 | -15.22% | -326.36% | 0.04x | 1.09x | $-10.85 Million |
| 2024 | -1.37% | -35.26% | 0.04x | 1.10x | $-4.94 Million |
Industry Comparison
This section compares NuGene International Inc's net assets metrics with peer companies in the Software - Application industry.
Industry Context
- Industry: Software - Application
- Average net assets among peers: $1,558,090,989
- Average return on equity (ROE) among peers: -47.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NuGene International Inc (NUGN) | $41.93 Million | 34.54% | 0.06x | $585.17K |
| Abaxx Technologies Inc (ABXXF) | $42.03 Million | -128.66% | 0.23x | $201.28 Million |
| Acceleware Ltd (ACWRF) | $2.15 Million | -4.58% | 1.86x | $8.62 Million |
| Adobe Systems Incorporated (ADBE) | $6.67 Billion | 12.49% | 0.51x | $104.01 Billion |
| Adcore Inc (ADCOF) | $9.73 Million | -22.96% | 0.49x | $3.03 Million |
| ADEIA CORP (ADEA) | $618.15 Million | -0.05% | 1.00x | $2.50 Billion |
| Automatic Data Processing Inc (ADP) | $6.19 Billion | 22.71% | 4.21x | $84.26 Billion |
| Autodesk Inc (ADSK) | $2.04 Billion | 12.11% | 1.11x | $48.93 Billion |
| Allied Security Innovations Inc (ADSV) | $445.50K | -270.60% | 3.60x | $0.93 |
| AudioEye Inc (AEYE) | $10.59 Million | -98.53% | 1.31x | $49.31 Million |
| Affinity Networks Inc (AFFN) | $-470.19K | 0.00% | 0.00x | $0.97 |